Naratriptan and Flonase drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Naratriptan (naratriptan) and Flonase (fluticasone propionate). Common drug interactions include arthralgia among females.

The phase IV clinical study analyzes what interactions people have when they take Naratriptan and Flonase. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Naratriptan?

Naratriptan has active ingredients of naratriptan. It is often used in migraine. eHealthMe is studying from 1,481 Naratriptan users. Check the latest studies of Naratriptan.

What is Flonase?

Flonase has active ingredients of fluticasone propionate. It is often used in allergies. eHealthMe is studying from 75,441 Flonase users. Check the latest studies of Flonase.



On Jul, 19, 2026

25 people who take Naratriptan and Flonase together, and have interactions are studied.

Naratriptan and Flonase drug interactions.

What are the common drug interactions of Naratriptan and Flonase, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Back pain
  3. Hypertensive emergency
  4. Pruritus (severe itching of the skin)
  5. Rash
  6. Vomiting
  7. Injection site discolouration
  8. Injection site pain
  9. Abdominal pain
  10. Anaemia (lack of blood)

male:

n/a

What are the common drug interactions of Naratriptan and Flonase, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Chest discomfort
  2. Dizziness
  3. Dyspnoea (difficult or laboured respiration)
  4. Hospitalisation
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Nausea (feeling of having an urge to vomit)
  7. Poor quality sleep
  8. Vomiting

20-29:

n/a

30-39:

  1. Anaemia (lack of blood)
  2. Arthralgia (joint pain)
  3. Complications of transplanted kidney
  4. Confusional state
  5. Dyspnoea (difficult or laboured respiration)
  6. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  7. Pain
  8. Pain in extremity
  9. Procedural pain
  10. Pruritus (severe itching of the skin)

40-49:

  1. Arthralgia (joint pain)
  2. Asthma
  3. Back pain
  4. Erythema (redness of the skin)
  5. Nausea (feeling of having an urge to vomit)
  6. Pain
  7. Cellulitis (infection under the skin)
  8. Confusional state
  9. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  10. Disturbance in attention

50-59:

  1. Arthralgia (joint pain)
  2. Injection site discolouration
  3. Injection site pain
  4. Pain in extremity
  5. Body height decreased
  6. Injection site extravasation (flow of (blood or lymph) from injection site)
  7. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  8. Ocular discomfort (a generic expression when there is lack of ease in/about the eyes)
  9. Weight decreased
  10. Hypertensive emergency

60+:

  1. Blepharitis (chronic inflammation of the eyelid)
  2. Breast cancer metastatic
  3. Dry eye (lack of adequate tears)
  4. Eye injury
  5. Lacrimation increased
  6. Meibomian gland dysfunction (dry eyes)
  7. Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
  8. Rosacea (a skin condition that causes facial redness)
  9. Sweat gland tumour

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 4 people, 16.00%
  2. Asthma: 4 people, 16.00%
  3. Stress And Anxiety: 3 people, 12.00%
  4. Depression: 3 people, 12.00%
  5. Neck Pain: 2 people, 8.00%
  6. Nausea (feeling of having an urge to vomit): 2 people, 8.00%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 8.00%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.00%
  9. Allergic Rhinitis: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Naratriptan and Flonase?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Naratriptan and Flonase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Naratriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Flonase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naratriptan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flonase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on naratriptan and fluticasone propionate (the active ingredients of Naratriptan and Flonase, respectively), and Naratriptan and Flonase (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: